1. Management of hospitalized influenza A patients during the season 2018/19
- Author
-
Marianna Traugott, Erich Pawelka, Georg-Christian Funk, Michael Turner, Sara Omid, Boris Lindner, Alexander Zoufaly, Christoph Porpaczy, Sabine Publig, Christoph Wenisch, Tamara Seitz, Hasan Kelani, and Mario Karolyi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Oseltamivir ,chemistry.chemical_compound ,Interquartile range ,Internal medicine ,Clavulanic acid ,Influenza, Human ,medicine ,Humans ,Medical prescription ,Aged ,business.industry ,General Medicine ,Amoxicillin ,medicine.disease ,Anti-Bacterial Agents ,Hospitalization ,Pneumonia ,Pulmonology ,chemistry ,Female ,Seasons ,business ,Cefuroxime ,medicine.drug - Abstract
BACKGROUND Diagnosis and treatment of influenza patients are often provided across several medical specialties. We compared patient outcomes at an infectious diseases (ID), a rheumatology (Rheu) and a pulmonology (Pul) department. MATERIAL AND METHODS In this prospective observational multicenter study we included all influenza positive adults who were hospitalized and treated at flu isolation wards in three hospitals in Vienna during the season 2018/2019. RESULTS A total of 490 patients (49% female) with a median age of 73 years (interquartile range [IQR] 61-82) were included. No differences regarding age, sex and most underlying diseases were present at admission. Frequencies of the most common complications differed: acute kidney failure (ID 12.7%, Rheu 21.2%, Pulm 37.1%, p
- Published
- 2021
- Full Text
- View/download PDF